| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.46B | 36.27B | 32.68B | 31.10B | 27.81B | 25.77B |
| Gross Profit | 8.94B | 8.12B | 6.57B | 6.22B | 6.07B | 5.90B |
| EBITDA | 4.60B | 4.39B | 3.42B | 3.03B | 2.49B | 1.88B |
| Net Income | 2.56B | 2.39B | 1.78B | 1.40B | 1.05B | 747.76M |
Balance Sheet | ||||||
| Total Assets | 21.34B | 22.49B | 20.06B | 17.52B | 16.24B | 16.80B |
| Cash, Cash Equivalents and Short-Term Investments | 5.20B | 5.68B | 5.92B | 5.07B | 4.91B | 5.02B |
| Total Debt | 1.90B | 1.95B | 2.55B | 2.13B | 2.73B | 3.46B |
| Total Liabilities | 7.76B | 8.87B | 8.05B | 7.09B | 6.79B | 7.39B |
| Stockholders Equity | 13.51B | 13.55B | 11.95B | 10.38B | 9.40B | 9.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.39B | 1.25B | 1.60B | 1.72B | -740.75M |
| Operating Cash Flow | 0.00 | 3.56B | 1.42B | 1.65B | 1.84B | -607.39M |
| Investing Cash Flow | 0.00 | -2.28B | -233.18M | -360.39M | -9.40M | -612.07M |
| Financing Cash Flow | 0.00 | -1.51B | -432.38M | -1.28B | -1.89B | 1.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥26.71B | 15.44 | ― | 2.18% | 9.56% | 30.03% | |
80 Outperform | ¥31.14B | 8.18 | ― | 2.93% | 2.11% | 5.55% | |
73 Outperform | ¥30.58B | 13.32 | ― | 2.22% | 9.57% | 315.38% | |
72 Outperform | ¥29.89B | 13.94 | ― | 3.40% | 12.64% | 30.73% | |
72 Outperform | ¥29.46B | 16.05 | ― | 2.45% | 19.04% | 30.67% | |
65 Neutral | ¥30.97B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |